Journal of Clinical Case Reports

Division of Infectious Diseases, University of Wayne State, Detroit, Michigan, USA

Publications

• Case Report   
  A Case Report of Invasive Aspergillosis in a Patient Treated with Ruxolitinib
  Author(s): Arvinder Cheema, Sajjad Ali* and Pranatharthi Chandrasekar
  
  Invasive Aspergillosis (IA) is a severe opportunistic infection that typically affects immunocompromised patients. Ruxolitinib is a selective Janus kinase inhibitor which is used for steroid-refractory acute Graft-vs.-Host Disease (GVHD). Several case reports have described serious opportunistic infections in Ruxolitinib-treated Primary Myelofibrosis (PMF) patients but no routine antifungal prophylaxis is recommended in these patients. We present an interesting case of 77-year-old man with previous history of treated MDS several years ago currently on Ruxolitinib for GVHD who was found to have new cavitary lung lesion on routine imaging... Read More»
  DOI: 10.37421/2165-7920.2023.13.1575

  Abstract HTML PDF